The specific aims of this study are to 1) assess the maximum tolerated dose of S when given as a loading dose followed by weekly maintainance therapy of 12 weeks in patients with selected tumors (ovarian, non-small cell lung cancer and prostate cancer) and 2) to assess the efficacy of SU101 on this dosing regimen these tumor types.
Showing the most recent 10 out of 1085 publications